1Division of Gastroenterology and Hepatology University of California, San Francisco 513 Parnassus Avenue, S-357 San Francisco, CA 94143. Electronic address: Monika.Sarkar@ucsf.edu.
2Division of Gastroenterology & Hepatology;Mayo Clinic and Foundation200 First St Rochester MN 55905.
3Director, Viral Hepatitis Center, University of California San Francisco 513 Parnassus Ave., S357 San Francisco, CA 94143-0538.
4Hepatology & Liver Transplantation Unit, La Fe Hospital and Ciberehd, Universidad Valencia, Valencia, Spain C/Bulevar Sur sn (Torre F-5) 46026 Valencia, Spain.
A growing literature has highlighted important differences in transplant-related outcomes between men and women. In the United States there are fewer women than men on the liver transplant waitlist and women are two times less likely to receive a deceased or living-related liver transplant. Sex based differences exist not only in waitlist but also in posttransplant outcomes, particularly in some specific liver diseases, such as hepatitis C. In the era of individualized medicine, recognition of these differences in the approach to pre and post-LT care may impact short and long-term outcomes.